1-8 of 8
D. Ayers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The VITAL Trial: Phase II Trial of V osaroxin and I nfusional Cytarabine for Frontline T reatment of a cute Myeloid L eukemia

Stephen A Strickland, MD MSCI, Nikolai A. Podoltsev, MD PhD, Sanjay R Mohan, MD MSCI, Amer M. Zeidan, MBBS, MHS, Merrida A Childress, PhD, Gregory D Ayers, MS, Michael T Byrne, DO, Steven D. Gore, MD, Robert K. Stuart, MD, Michael R. Savona, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 180.
https://doi.org/10.1182/blood-2019-131520
Published: 2019
Journal Articles

Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase Inhibition

Tamara K Moyo, MD PhD, Justin M. Watts, MD, Barry S. Skikne, MD, Jason H. Mendler, MD PhD, Virginia M. Klimek, MD, Sheau-Chiann Chen, PhD, Run Fan, PhD MS, Ingrid A Anderson, PhD, Andrew Sochacki, MD, Stephen A. Strickland, MD, Michael T Byrne, DO, Terrence J Bradley, MD, Gregory D Ayers, MS, Sanjay R Mohan, MD MSCI, Michael R. Savona, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4236.
https://doi.org/10.1182/blood-2019-130003
Published: 2019
Journal Articles

Phase II Trial of Vosaroxin and Infusional Cytarabine for Frontline Treatment of Acute Myeloid Leukemia (VITAL) Patients Eligible for Intensive Chemotherapy: A Planned Interim Analysis

Stephen A. Strickland, MD MSCI, Nikolai A. Podoltsev, MD PhD, Sanjay R. Mohan, MD MSCI, Amer M. Zeidan, MD, Gregory D. Ayers, MS, Molly Olson, MS, Steven D. Gore, MD, Robert K. Stuart, MD, Michael R. Savona, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2630.
https://doi.org/10.1182/blood.V130.Suppl_1.2630.2630
Published: 2017
Journal Articles

Preliminary Results from a Phase I Dose Escalation Trial of Ruxolitinib and the PI3Kδ Inhibitor TGR-1202 in Myelofibrosis

Tamara K Moyo, MD PhD, Andrew Sochacki, MD, Gregory D Ayers, MS, Michael T. Byrne, DO, Stephen A. Strickland, Sanjay R. Mohan, MD, Jill Harrison, Lynne D Berry, Channing V Dudley, Rachel Severs, Laura Dugger, Hari P. Miskin, MS, Amy Cavers, Peter Sportelli, Laura C Michaelis, MD, Ruben A. Mesa, MD, Michael R. Savona, MD
Journal: Blood
Blood (2016) 128 (22): 1125.
https://doi.org/10.1182/blood.V128.22.1125.1125
Published: 2016
Journal Articles

Polymorphisms in VKORC1, CYP2C9, and CYP4F2 and Warfarin Dose in the Pediatric Population

Susan I. Vear, MD, Gregory D. Ayers, MS, C. Michael Stein, MD, MBChB, Richard H. Ho, MD, MSCI
Journal: Blood
Blood (2012) 120 (21): 4358.
https://doi.org/10.1182/blood.V120.21.4358.4358
Published: 2012
Journal Articles

Baseline Osteopenia and Osteoporosis in Untreated Non-Hodgkin’s Lymphoma Patients.

Michael A. Thompson, MD, PhD, Auris Huen, PharmD, Gregory D. Ayers, MS, Bela B. Toth, DDS, Rena V. Sellin, MD, Ana O. Hoff, MD, William A. Murphy, Jr., MD, F.B. Hagemeister, MD
Journal: Blood
Blood (2006) 108 (11): 4607.
https://doi.org/10.1182/blood.V108.11.4607.4607
Published: 2006
Journal Articles

Age Is Not a Prognostic Variable With Autotransplants for Multiple Myeloma

D.S. Siegel, K.R. Desikan, J. Mehta, S. Singhal, A. Fassas, N. Munshi, E. Anaissie, S. Naucke, D. Ayers, D. Spoon, D. Vesole, G. Tricot, B. Barlogie
Journal: Blood
Blood (1999) 93 (1): 51–54.
https://doi.org/10.1182/blood.V93.1.51
Published: 1999
Journal Articles

Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma

B. Barlogie, S. Jagannath, K.R. Desikan, S. Mattox, D. Vesole, D. Siegel, G. Tricot, N. Munshi, A. Fassas, S. Singhal, J. Mehta, E. Anaissie, D. Dhodapkar, S. Naucke, J. Cromer, J. Sawyer, J. Epstein, D. Spoon, D. Ayers, B. Cheson, J. Crowley
Journal: Blood
Blood (1999) 93 (1): 55–65.
https://doi.org/10.1182/blood.V93.1.55
Published: 1999